Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

Etats-Unis|Canada
English|French

Kodiak Sciences Inc

(NASDAQ: KOD)
Ajouter à Portefeuille
-3,32 (-10,29%)
en date du nov 21, 2019

Profil
Symbole KOD
Marché NASDAQ
Informations de contact
2631 HANOVER STREET
PALO ALTO, CA USA
P: 650-281-0850
Président Victor Perlroth
Bénéfices à vue d'oeuil
Bénéfices 09/30/19
-0.33
06/30/19
-0.31
03/31/19
-0.21
12/31/18
0.68
Ratio prix/bénéfices N/A
Croissance du BPA 48,96
Most Recent Earnings ($) -0,33
Annual EPS ($) -1,25
Résumé business
Kodiak Sciences Inc. operates as a clinical stage biopharmaceutical company. It specializes in novel therapeutics to treat chronic and retinal diseases. The company's product candidates consists of KSI-301 for wet AMD KSI-301 for diabetic eye disease KSI-501 for DME and Uveitis KSI-201 for treatment resistant wet AMD and KSI-401 for dry AMD which are in clinical stage. Kodiak Sciences Inc. is based in CA United States.
Industrie/Secteur SIC-2836 Biological Products, (No Disgnostic Substanc
Medical - Biomedical
Indices Russell 3000
Indices Russell 2000
Top 100 Stocks